We are very happy to announce that we passed the Wyss 4-step evaluation process and are selected as a new project at the Wyss Zurich. As a Wyss Zurich project, we receive generous funding and are granted access to the Wyss facilities and teams, which will help speed up the development of our lead product PHR-001. We are thrilled to be part of Wyss Zurich and bring an alternative conditioning regimen to all AML patients.
Wyss Zurich is a unique accelerator, embedded within the ETH Zurich and the University of Zurich. They unite world-leading experts to form multidisciplinary teams, pooling their knowledge and expertise.
Comments